Figure 3From: Aqueous extracts from dietary supplements influence the production of inflammatory cytokines in immortalized and primary T lymphocytes The aqueous extract from Immuplex ® and Congaplex ® alter cytokine release following activation. CEM (A) and Jurkat (B) cells were pre-treated the aqueous extract from Immuplex® or Congaplex® for one hour prior to treatment with PMA and PHA as described in Materials and Methods. Cells were harvested 24 hours after PMA/PHA treatment and media was assayed for cytokine concentrations using a multiplex bead assay. Data are representative of 3 independent experiments, using independent cell cultures, all of which produced similar results. Data represents the average of four replicates ± standard deviation. Data is presented as the percentage of cytokine concentration in cells treated with PMA and PHA in the absence of Immuplex® or Congaplex® treatment (vehicle). * = significantly higher than vehicle treatment. †= significantly lower than vehicle treatment.Back to article page